H
Helen K. Edelberg
Researcher at Beth Israel Deaconess Medical Center
Publications - 8
Citations - 3011
Helen K. Edelberg is an academic researcher from Beth Israel Deaconess Medical Center. The author has contributed to research in topics: Poison control & Gait. The author has an hindex of 7, co-authored 8 publications receiving 2798 citations. Previous affiliations of Helen K. Edelberg include Icahn School of Medicine at Mount Sinai & Harvard University.
Papers
More filters
Journal ArticleDOI
Gait variability and fall risk in community-living older adults: A 1-year prospective study
TL;DR: Findings show both the feasibility of obtaining stride-to-stride measures of gait timing in the ambulatory setting and the potential use ofgait variability measures in augmenting the prospective evaluation of fall risk in community-living older adults.
Journal ArticleDOI
Increased gait unsteadiness in community-dwelling elderly fallers
TL;DR: Stride-to-stride temporal variations of gait are relatively unchanged in community-dwelling elderly nonfallers, but are significantly increased in elderly fallers, which may be useful in assessing fall risk in the elderly.
Journal ArticleDOI
Medication management capacity in highly functioning community-living older adults: detection of early deficits.
TL;DR: The Drug Regimen Unassisted Grading Scale (DRUGS) was developed and employed in testing the hypothesis that the inability to take medication independently may correlate with the presence of cognitive impairment.
Journal ArticleDOI
One-Year Follow-Up of Medication Management Capacity in Highly Functioning Older Adults
TL;DR: It is found that impairment in the ability to take medication independently predicts early functional decline and this geriatric screening tool utilizes a stepwise progression of four tasks: identification, access, dosage, and timing.
Journal ArticleDOI
The biology of Alzheimer's disease
Helen K. Edelberg,Jeanne Y. Wei +1 more
TL;DR: This review will explore the possibility that AD is in part an inflammatory or immunological process, the potential role of oxidative DNA damage from oxygen free radical metabolites, and/or the putative role of excitotoxicity or ischemic neurological injury.